| Basics |
ZOETIS INC.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
|
| IPO Date: |
February 1, 2013 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$67.95B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.12 | 0.99%
|
| Avg Daily Range (30 D): |
$1.53 | 0.99%
|
| Avg Daily Range (90 D): |
$1.70 | 1.08%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.46M |
| Avg Daily Volume (30 D): |
2.42M |
| Avg Daily Volume (90 D): |
2.43M |
| Trade Size |
| Avg Trade Size (Sh.): |
95 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Inst.Trades: |
25,594 |
| Avg Inst. Trade: |
$7.73M |
| Avg Inst. Trade (30 D): |
$14.04M |
| Avg Inst. Trade (90 D): |
$15.22M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$32.74M |
| Avg Closing Trade (30 D): |
$56.11M |
| Avg Closing Trade (90 D): |
$71.57M |
| Avg Closing Volume: |
286.49K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$5.82
|
$1.61
|
$1.41
|
|
Diluted EPS
|
$5.81
|
$1.61
|
$1.41
|
|
Revenue
|
$ 9.39B
|
$ 2.46B
|
$ 2.22B
|
|
Gross Profit
|
$ 6.71B
|
$ 1.81B
|
$ 1.6B
|
|
Net Income / Loss
|
$ 2.62B
|
$ 718M
|
$ 631M
|
|
Operating Income / Loss
|
$ 3.32B
|
$ 902M
|
$ 810M
|
|
Cost of Revenue
|
$ 2.68B
|
$ 649M
|
$ 622M
|
|
Net Cash Flow
|
$ -139M
|
$ -286M
|
$ -266M
|
|
PE Ratio
|
26.39
|
|
|
|
|
|
